Search results for "HLA-DQ2"

showing 4 items of 4 documents

Gluten Stimulation Induces an in vitro Expansion of Peripheral Blood Tγδ Cells from HLA-DQ2-Positive Subjects of Families of Patients with Celiac Dis…

1998

The intestinal gluten sensitivity formally known as celiac disease (CD) is characterized by an evident involvement of local immune response and it is associated with the expression of HLA-DQ2 allele. The major role in the disease seems to be played by the T lymphocyte population bearing gamma delta T cell receptor (T gamma delta cells) which are increased both in peripheral blood and intestinal mucosae of celiac patients. In this paper data on the effects of in vitro gluten stimulation on lymphocytes expressing the T gamma delta phenotype are reported. Gluten seems to be able to induce the expansion of the T gamma delta cell population both in CD patients and their HLA-DQ2-positive asymptom…

AdultMaleAdolescentGlutensT-LymphocytesImmunologyEnzyme-Linked Immunosorbent AssayStimulationDiseasePolymerase Chain ReactionImmune systemHLA-DQ AntigensGeneticsHumansMedicineReceptors ImmunologicAlleleChildCells CulturedGenetics (clinical)chemistry.chemical_classificationbusiness.industryHLA-DQ2nutritional and metabolic diseasesMiddle AgedGlutendigestive system diseasesIn vitroPeripheral bloodCeliac DiseasePhenotypechemistryChild PreschoolImmunologyLeukocytes MononuclearFemaleInterleukin-4businessExperimental and Clinical Immunogenetics
researchProduct

High Proportions of People With Nonceliac Wheat Sensitivity Have Autoimmune Disease or Antinuclear Antibodies.

2015

BACKGROUND & AIMS: There is much interest in wheat sensitivity among people without celiac disease (CD), but little is known about any risks associated with the condition. We evaluated the prevalence of autoimmune diseases (ADs) among patients with nonceliac wheat sensitivity (NCWS), and investigated whether they carry antinuclear antibodies (ANA). METHODS: We performed a retrospective study of 131 patients diagnosed with NCWS (121 female; mean age, 29.1 years) at 2 hospitals in Italy from January 2001 through June 2011. Data were also collected from 151 patients with CD or irritable bowel syndrome (IBS) (controls). Patient medical records were reviewed to identify those with ADs. We al…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaAnti-nuclear antibodyNonceliac Wheat Sensitivity; Autoimmune Disease; Antinuclear Antibodies.Nonceliac Wheat SensitivityWheat HypersensitivityAutoimmune DiseaseThyroiditisAutoimmune DiseasesRisk FactorsInternal medicineHLA-DQ AntigensmedicinePrevalenceHumansProspective StudiesProspective cohort studyIrritable bowel syndromeRetrospective StudiesAutoimmune diseaseAntinuclear Antibodies.Hepatologybusiness.industryMedical recordGastroenterologyHLA-DQ2Retrospective cohort studyMiddle Agedmedicine.diseaseCeliac DiseaseHaplotypesItalyAntibodies AntinuclearImmunologyFemalebusinessBiomarkersGastroenterology
researchProduct

P609 New and old criteria for diagnosing celiac disease

2019

Background CD is an immune-mediated systemic disease elicited by gluten and related prolamines, it affects genetically susceptible individuals and it is characterized by the presence of gluten-dependent clinical manifestations, CD-specific antibodies, HLA-DQ2 or HLA-DQ8 haplotypes and enteropathy. According to the guidelines published by ESPGHAN in 2012, it is possible to diagnose celiac disease without intestinal biopsy, in symptomatic children and adolescents with very high levels of transglutaminases type-2 antibodies and positive HLA DQ2/DQ8. Aims The aim of our study is to analyse two groups of patients: one in which diagnosis was based on the new ESPGHAN criteria, and another based on…

Systemic diseasemedicine.medical_specialtybusiness.industryIncidence (epidemiology)HLA-DQ2nutritional and metabolic diseasesDiseasemedicine.diseaseThyroiditisSerologyInternal medicinemedicineEnteropathybusinessPediatric gastroenterologyAbstracts
researchProduct

Adherence to dietary treatment and clinical factors associated with anti-transglutaminase antibodies in celiac disease during the follow-up

2021

Introduction In clinical practice, celiac disease (CD) is monitored through anti-transglutaminase (TGA-IgA) antibody levels. The normalization of serum levels in successive periodic measurements indicates good response and adherence to dietary treatment. Objectives To evaluate the factors associated with the evolution of TGA-IgA antibodies and their association with dietary non-compliance and diseases related to CD. Methods This prospective observational study was carried out in 254 participants, who were recruited from patients from a hospital in southern Spain. Information about sex, age, serological test results, HLA DQ2/DQ8 haplotypes, mucosal atrophy, gastrointestinal and extra-intesti…

0301 basic medicinemedicine.medical_specialtyAbdominal painScience (General)PopulationDiseaseSerology03 medical and health sciencesQ1-3900302 clinical medicineAtrophyWeight lossInternal medicinemedicineTGA-IgA antibodiesCeliac diseaseeducationH1-99education.field_of_studyMultidisciplinarybiologybusiness.industryHLA-DQ2medicine.diseaseDietSocial sciences (General)030104 developmental biologyDietary non-complianceAnti-transglutaminase antibodiesbiology.proteinmedicine.symptombusiness030217 neurology & neurosurgeryResearch ArticleHeliyon
researchProduct